Joined Sep 2021
August 17, 2023
The reduced function allele SLCO1B1 c.521T>C is of no practical relevance for the...
Sandra Nađ Škegro, Luka Panezić, Livija Šimičević, et al.
December 19, 2022
Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates...
Ivana Šušak Sporiš, Nada Božina, Iva Klarica Domjanović, et al.
November 13, 2022
Loss of function ABCG2 c.421C>A (rs2231142) polymorphism increases steady-state ex...
July 13, 2022
Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not...
Vladimir Trkulja and Ivan Kodvanj
April 29, 2022
Comparing Mid-Term Outcomes of Cox-Maze Procedure and Pulmonary Vein Isolation for At...
Davorin Sef, Vladimir Trkulja, Shahzad Raja, et al.
May 28, 2022
Fluvoxamine for COVID-19 outpatients: for the time being, we might prefer to curb our...
December 07, 2021
Tocilizumab for reduction of mortality in severe COVID-19 patients: how should we GRA...
November 02, 2021
Mid-Term Outcomes of Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to L...
Davorin Sef, Alessandra Verzelloni Sef, Vladimir Trkulja, et al.
November 18, 2021
Fluvoxamine for COVID-19 ICU patients?
September 25, 2021
DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adver...
Nada Bozina, Ivan Bilić, Lana Ganoci, et al.